Đang chuẩn bị liên kết để tải về tài liệu:
Positive response to Icotinib in metastatic lung adenocarcinoma with acquiring EGFR Leu792H mutation after AZD9291 treatment: A case report

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have been emerged as the standard selection in non-small cell lung cancer (NSCLC) patients with EGFR sensitive mutations. | Positive response to Icotinib in metastatic lung adenocarcinoma with acquiring EGFR Leu792H mutation after AZD9291 treatment A case report

TÀI LIỆU LIÊN QUAN

Higher PEEP improves outcomes in ARDS patients with clinically objective positive oxygenation response to PEEP: A systematic review and meta-analysis

MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2- positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy

Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer

Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: A large, multicenter, observational study

Báo cáo khoa học: "Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer"

Báo cáo y học: " Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia"

Báo cáo y học: " Use of Non-parametric Item Response Theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS)"

Báo cáo hóa học: " Research Article Non-Constant Positive Steady States for a Predator-Prey Cross-Diffusion Model with Beddington-DeAngelis Functional Response"

Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia

Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: Results of a randomized study - SAKK 22/99
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.